Advertisement
Gynecologic Oncology
Advanced searchSave search
1 – Late Breaking Abstract|Moderator: Don Dizon, MD, Massachusetts General Hospital/Harvard University, Boston, MA, USA| Volume 145, SUPPLEMENT 1, 219, June 2017

A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study

DOI:https://doi.org/10.1016/j.ygyno.2017.03.504
A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study
Previous ArticleFertility-sparing surgery for young patients with sarcoma involving the uterine cervix
Next ArticleTreatment with olaparib monotherapy in the maintenance setting significantly improves progression-free survival in patients with platinum-sensitive relapsed ovarian cancer: Results from the phase III SOLO2 study
      Objective: To compare overall survival (OS) of maintenance chemotherapy (P and PP) to surveillance (S) in women with advanced ovarian/fallopian tube/peritoneal (O/PC/FT) cancer who attained complete clinical response (CCR) following first-line platinum-taxane therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Identification

      DOI: https://doi.org/10.1016/j.ygyno.2017.03.504

      Copyright

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX